| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-18 |
| | 10-K | 10-K | 10-K | S-1 |
| Revenues: |
| Licenses and subscriptions | 12.6 | 25.5 | | |
| Asia | 6.9 | 13.1 | | |
| Europe | | 18.6 | | |
| Virtual Care Infrastructure | 65.0 | 36.6 | | |
| Other | 74.3 | 30.0 | | |
| Total revenues | 158.8 | 123.8 | 5.4 | |
| Revenue growth [+] | 28.3% | 2194.2% | | |
| Licenses and subscriptions | -50.8% | | | |
| Asia | -47.2% | | | |
| Virtual Care Infrastructure | 77.7% | | | |
| Integrated Care Management | -43.5% | 758.3% | | |
| Cost of goods sold | 88.6 | 84.0 | 1.2 | |
| Gross profit | 70.2 | 39.8 | 4.2 | |
| Gross margin | 44.2% | 32.2% | 78.1% | |
| Selling, general and administrative [+] | 64.7 | 62.9 | 4.9 | |
| Sales and marketing | 16.0 | 10.6 | | |
| General and administrative | 48.8 | 52.3 | 4.9 | |
| Research and development | 7.9 | 7.6 | 0.9 | |
| Equity in earnings | | -0.6 | -0.1 | |
| Other operating expenses | 44.2 | 2.0 | | |
| EBITDA [+] | -41.0 | -29.6 | -1.7 | |
| EBITDA growth | 38.8% | 1653.9% | | |
| EBITDA margin | -25.8% | -23.9% | -31.2% | |
| Depreciation | 7.8 | 4.4 | 0.0 | |
| EBITA | -48.8 | -34.0 | -1.7 | |
| EBITA margin | -30.7% | -27.4% | -31.6% | |
| Amortization of intangibles | 14.0 | 12.4 | 0.3 | |
| EBIT [+] | -62.8 | -46.3 | -2.0 | |
| EBIT growth | 35.6% | 2209.1% | | |
| EBIT margin | -39.6% | -37.4% | -37.2% | |
| Non-recurring items [+] | 98.6 | 334.2 | | |
| Asset impairment | 114.1 | 297.9 | | |
| Unusual expense | -37.7 | | | |
| Interest expense | 26.5 | 19.5 | 0.1 | |
| Interest expense | 26.5 | 19.5 | 0.1 | |
| Other income (expense), net [+] | -44.4 | 57.3 | 0.1 | |
| Gain (loss) on debt retirement | -14.6 | 0.2 | | |
| Unrealized gain/loss on derivatives | 7.5 | 53.8 | | |
| Change in fair value of warrants | 0.2 | 1.6 | | |
| Extraordinary gain | | 0.6 | | |
| Pre-tax income | -232.3 | -342.8 | -2.1 | |
| Income taxes | -9.4 | -2.4 | -0.1 | |
| Tax rate | 4.0% | 0.7% | 2.4% | |
| Minority interest | 0.1 | 0.1 | | |
| Net income | -223.0 | -341.0 | -2.2 | |
| Net margin | -140.4% | -275.5% | -40.5% | |
| |
| Basic EPS [+] | ($15.17) | ($31.86) | ($0.04) | |
| Growth | -52.4% | 76200.6% | | |
| Diluted EPS [+] | ($15.17) | ($31.86) | ($0.04) | |
| Growth | -52.4% | 76200.6% | | |
| |
| Shares outstanding (basic) [+] | 14.7 | 10.7 | 52.3 | |
| Growth | 37.3% | -79.6% | | |
| Shares outstanding (diluted) [+] | 14.7 | 10.7 | 52.3 | |
| Growth | 37.3% | -79.6% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |